The Morphology Core is dedicated to supporting each of the specific proposals in this project from the following aspects: 1.) Assessment of viability of transfected hepatocytes in vitro and in vivo; 2.) Identification and quantitation of transplanted cells in recipients; and 3.) Assessment of short and long-term pathological alterations in recipients subjected to surgical (delivery) procedures, retrovirus vectors, foreign genes. The several components of the project, involving multiple animal species (rabbit, dog, mouse and pig), harvesting of hepatocytes, their growth in culture, virus-mediated gene transfer and transplantation by each of several surgical routes, all require a contribution from this core. The methods to be used include: 1.) Routine histology to provide standard sections and stains on paraffin-embedded fixed tissues; 2.) Immunohistochemistry with vacuum embedding at low temperature to maximize antigen (protein) and mRNA preservation; 3.) Frozen sections for immunochemistry, enzyme histochemistry and radioautography providing for a variety of markers of gene expression (ie: E. coli beta-galactosidase, mRNA in situ); 4.) Transmission and scanning electron microscopy for characterization of cell type and cell preservation; and 5.) Immunoelectron microscopy for localization of gene products as measure of functional integrity and orderly expression (ie: alpha1 antitrypsin, CAT) and for detection of retroviral products.

Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Baylor College of Medicine
Department
Type
DUNS #
074615394
City
Houston
State
TX
Country
United States
Zip Code
77030
Tarlow, Branden D; Pelz, Carl; Naugler, Willscott E et al. (2014) Bipotential adult liver progenitors are derived from chronically injured mature hepatocytes. Cell Stem Cell 15:605-18
Wu, Y; Teng, B B; Brandt, M L et al. (1999) Normal perinatal rise in serum cholesterol is inhibited by hepatic delivery of adenoviral vector expressing apolipoprotein B mRNA editing enzyme (Apobec1) in rabbits. J Surg Res 85:148-57
Muzzin, P; Eisensmith, R C; Copeland, K C et al. (1997) Hepatic insulin gene expression as treatment for type 1 diabetes mellitus in rats. Mol Endocrinol 11:833-7
Kuzmin, A I; Finegold, M J; Eisensmith, R C (1997) Macrophage depletion increases the safety, efficacy and persistence of adenovirus-mediated gene transfer in vivo. Gene Ther 4:309-16
Fang, B; Wang, H; Gordon, G et al. (1996) Lack of persistence of E1- recombinant adenoviral vectors containing a temperature-sensitive E2A mutation in immunocompetent mice and hemophilia B dogs. Gene Ther 3:217-22
Brandt, M L (1996) Gene therapy in pediatric surgery. Semin Pediatr Surg 5:197-205
Bowles, N E; Eisensmith, R C; Mohuiddin, R et al. (1996) A simple and efficient method for the concentration and purification of recombinant retrovirus for increased hepatocyte transduction in vivo. Hum Gene Ther 7:1735-42
Brandt, M L; Eckert, J W; Buerkle, C J et al. (1996) The subcutaneous spleen: a new model for percutaneous access to the portal venous system. J Invest Surg 9:161-6
Eckert, J W; Buerkle, C J; Major, A M et al. (1995) In situ hybridization utilizing a Y chromosome DNA probe. Use as a cell marker for hepatocellular transplantation. Transplantation 59:109-11
Fang, B; Eisensmith, R C; Wang, H et al. (1995) Gene therapy for hemophilia B: host immunosuppression prolongs the therapeutic effect of adenovirus-mediated factor IX expression. Hum Gene Ther 6:1039-44

Showing the most recent 10 out of 25 publications